Financing life science: The ongoing saga ( 6 $5.2 Sacramento/N. California ...)

Financing life science: The ongoing saga

6 $5.2 Sacramento/N. California $20 +186% 2 $10 South Central $10 <74%> 5 $2 Other $1 <50%> 2 $.5

Source: PriceWaterhouseCooper's MoneyTree Report - Third Quarter, 2006

Wonder of all wonders: C......

Full article >>>

Source:wistechnology.com By Michael Rosen 12/04/06

Page: 1 2 3 4 5 6
Related biology technology :

1. Financing of biotech companies so far in 2005: A Midwest odyssey
2. Seed-Stage Venture Financing
3. Quintessence Secures Financing
4. Food science: increasing crop yields

Post Your Comments:

(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...

(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...

(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...

(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...

[0] Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results [0] NeurogesX Reports Third Quarter 2009 Results [0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix

...ced today,that the company initiated its pivotal P...tucel-L) in the treatment of advanced non-small ce... in the study was treated by,Dr. Lyudmila Bazhenov...sity,of California, San Diego School of Medicine.,...80821/LATH009-a ), (Photo: http://www.newscom.co...

...nderlying Cause of Cystic,Fibrosis; Oral Drug May ...ELD, N.J., Aug. 20 New phase 2 data,published tod...l drug,PTC124 demonstrates activity in nonsense-mu...eatment with PTC124 results in statistically signi...on of patients with,nonsense-mutation CF. The stud...

...ystems,(MMS) today announced a new partnership wit... the result of a legislative initiative that,estab...h benefit for North,Dakota state employees and oth...nce Pharmaceutical Care System(TM) will provide No...aining and technology to guide and,document the de...

Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2 NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3 NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4 PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2 PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3 PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4 PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5 North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2

NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes

(Date:11/4/2009)...t,s the cost of saving a teenage life? When it com...rescription medication abuse, there,s no price tag...aware that the lock-boxes they,ve installed are no... of prescription drugs. That,s why MEDNET(TM), a n..., has formed an exclusive partnership with Axius H...

(Date:11/4/2009)...l/ -- BIO-key International, Inc. (OTC Bulletin Bo...ntification software is showcasing donor and patie...being held at the New Orleans Convention Center fr...on product demonstrations of its state-of-the-art ...5 PM on Monday, October 26, Peter Lux, manager of ...

(Date:11/4/2009)...sity of North Carolina at Chapel Hill School of Me...isco have developed and experimentally tested a te...g drugs. , The researchers developed a computati...es of all known drugs are to the naturally occurri...ase targets within the cell. In a study published ...

Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2 MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3 BIO-key(R) International Exhibiting at AABB TXPO 2 Study points to new uses, unexpected side effects of already existing drugs 2 New Nominee for WHO Regional Director for Europe 57339 1 New Nominee for WHO Regional Director for Europe 57339 2 Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 1 Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 2 Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 3 Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 4 Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1 Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2 Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3 Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4

[0] MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse [0] BIO-key(R) International Exhibiting at AABB TXPO [0] Study points to new uses, unexpected side effects of already existing drugs

...erta has helped map out the animal,s life span and...species lived, says new research conducted in part...rises to me was that the overall pattern of surviv...than the catastrophic model we were expecting," sa...e and professor in the U of A,s Department of Biol...

...eceptors in breast cancer may play a role in resis...xifen treatment, according to a study in the May 1...Pak 1 is a member of a family of proteins involved...cell movement, and cell death. Previous studies h...y lead to more invasive breast cancer. , Goran ...

...nsible for singing and mating are shrinking when e...of Alberta research--the first proof that natural ...ild animal. , "These residues have been persisti...turbing," said Dr. Andrew Iwaniuk, a post-doctoral...chology. "It has been years since it has been used...

Other Biology News:Tyrannosaur survivorship -- tough times for teens 2 Pak1 expression increases tamoxifen resistance in breast cancer patients 2 Bird brains shrink from exposure to contaminants 2

Tyrannosaur survivorship -- tough times for teens Pak1 expression increases tamoxifen resistance in breast cancer patients Bird brains shrink from exposure to contaminants

Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion

...are designed to rapidly and reliably amplify unkno... APAgene provides hassle-free, ready-to use compon... necessary ingredients are provided in each kit. T...t-end amplification of large clones such as P1, YA...

Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam

...is designed to deparaffinize and perform Heat Indu...affin-embedded tissue sections mounted on glass mi...by melting the paraffin at the high temperature us...ation of the paraffin by detergent. Formaldehyde f...

Biology Products:

Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion APAgene BAC End Amplification Kit w/o Enzyme from Bio S&T Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam PT Module^TM Deparaffinization and Heat-Induced Epitope Retrieval Solution (100X) from Lab Vision

( 6 $5.2 Sacramento/N. California ...)Financing life science: The ongoing saga